Paroxysmal Atrial Fibrillation in Elderly: Worldwide Preliminary Data of LINAC-Based Stereotactic Arrhythmia Radioablation Prospective Phase II Trial

Treatment approach for elderly patients with atrial fibrillation (AF) is difficult. The present prospective phase-II trial evaluated LINAC-based stereotactic arrhythmia radioablation safety in this population. The reported data of the first 5 patients worldwide, showed no side effects, absence of AF...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Monaco, Antonio, Gregucci, Fabiana, Bonaparte, Ilaria, Troisi, Federica, Surgo, Alessia, Di Molfetta, Domenico, Vitulano, Nicola, Quadrini, Federico, Carbonara, Roberta, Martinelli, Gaetano, Guida, Pietro, Ciliberti, Maria Paola, Fiorentino, Alba, Grimaldi, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924125/
https://www.ncbi.nlm.nih.gov/pubmed/35310997
http://dx.doi.org/10.3389/fcvm.2022.832446
Descripción
Sumario:Treatment approach for elderly patients with atrial fibrillation (AF) is difficult. The present prospective phase-II trial evaluated LINAC-based stereotactic arrhythmia radioablation safety in this population. The reported data of the first 5 patients worldwide, showed no side effects, absence of AF episodes and without antiarrhythmic drugs. TRIAL REGISTRATION: ClinicalTrials.gov, identifier: NCT04575662.

Ejemplares similares